论文部分内容阅读
１９８３年至１９９３年，作者等收治经病理证实的丘脑胶质瘤３０例，其中活检８例，常规开颅手术切除肿瘤１５例，ＣＴ定位开颅显微激光切除肿瘤７例，无手术死亡，２５例获得随访（平均随访３．５年），１５例生存，平均生存２．８年，１０例死亡，平均生存０．９年。作者认为无颅内压增高、占位效应不明显的丘脑胶质瘤首选活检加放疗；颅内压增高严重，占位效应明显者宜开颅切除肿瘤。肿瘤较小者选择立体定向显微激光技术切除可获得较高的术后生存质量；肿瘤较大者以常规开颅手术切除为佳。
From 1983 to 1993, the authors treated 30 cases of pathologically confirmed thalamic glioma, including 8 cases of biopsy, 15 cases of routine tumor resections, and CT-guided craniotomy for removal of tumors in 7 cases. No operative death occurred. Twenty-five patients were followed up (mean follow-up 3.5 years), 15 patients survived, and the average survival was 2.8 years. Ten patients died and the average survival was 0.9 years. The authors believe that no increase in intracranial pressure, occupying effect is not obvious thalamic glioma preferred biopsy plus radiotherapy; severe intracranial pressure increased, obvious placeholder effect should be craniotomy to remove the tumor. For those with smaller tumors, stereotactic laser resection can be used to obtain higher postoperative quality of life. For larger tumors, routine craniotomy is preferred.